Article info
PDFCancer genetics
Original research
High likelihood of actionable pathogenic variant detection in breast cancer genes in women with very early onset breast cancer
- Correspondence to Professor D Gareth Evans, Manchester Centre for Genomic Medicine, Manchester Academic Health Sciences Centre (MAHSC), St Mary’s Hospital, University of Manchester, Manchester, UK; gareth.evans{at}mft.nhs.uk
Citation
High likelihood of actionable pathogenic variant detection in breast cancer genes in women with very early onset breast cancer
Publication history
- Received July 17, 2020
- Revised October 27, 2020
- Accepted October 31, 2020
- First published March 23, 2021.
Online issue publication
January 21, 2022
Article Versions
- Previous version (23 March 2021).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.